Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Clinical trial NCT01782963 · COMPLETED

Trial details

NCT number: NCT01782963
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-03-01
Primary completion: 2016-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.